Home/Pipeline/PG-011

PG-011

Cell Culture / FGFR1c Agonist

CommercialLaunched

Key Facts

Indication
Cell Culture / FGFR1c Agonist
Phase
Commercial
Status
Launched
Company

About PeptiGrowth

Develops synthetic peptide alternatives to growth factors for xeno-free cell culture in regenerative medicine.

View full company profile

Therapeutic Areas